Skip Navigation

British Journal of Anaesthesia 2007 98(2):275-276; doi:10.1093/bja/ael355
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow E-Letters: Submit a response to the article
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Wheeler, D. W.
Right arrow Articles by Kanai, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wheeler, D. W.
Right arrow Articles by Kanai, A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


© The Board of Management and Trustees of the British Journal of Anaesthesia 2007. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Lidocaine intranasal spray for treatment of trigeminal neuralgia

D. W. Wheeler

Cambridge, UK

E-mail: dww21@cam.ac.uk

The first 10% of the full text of this article appears below.

Editor—Kanai and colleagues1 are to be congratulated on their study of the efficacy of lidocaine 8% intranasal spray for the treatment of paroxysmal second division trigeminal neuralgia. They showed that 0.2 ml of lidocaine 8% applied to the sphenopalatine . . . [Full Text of this Article]

A. Kanai

Kitasato, Japan

E-mail: kanaiakifumi@aol.com


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?